Thrombin Human Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Thrombin Human Market size is expected to grow at an annual average of 4% during 2022-2028. Thrombin is defined as a naturally occurring enzyme that converts fibrinogen to fibrin to form blood clots. Thrombin was invented from a variety of sources and is referred to as a hemostatic aid. Thrombin was discovered in bovine plasma and now thrombin is derived from recombinant sources and human plasma. Thrombin is used at the end of the coagulation cascade and serves as a coagulation factor. Thrombin is also used to form antibodies to prothrombin, thrombin, cardiolipin, and factor V. Thrombin is also used near larger blood vessels during surgery to prevent disseminated intravascular coagulation (DIC) and death.

The following segmentation are covered in this report:

By End-User

• Hospitals
• Diagnostics Centers & Clinics
• Others

By Dosage Form

• Powder Forms
• Solution Forms

By Product

• Bovine Thrombin
• Human Thrombin
• Recombinant Thrombin

 Company Profile

• AMRESCO Inc.
• Baxter International, Inc.
• Bayer AG
• BD Biosciences
• CSL Behring
• Life Technologies Corporation
• Pfizer Inc.
• PromoCell GmbH
• Sigma-Aldrich Corporation
• Vitrolife AB

Scope of the report

The research study analyses the Thrombin Human Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Thrombin Human Market Report

• What was the Thrombin Human Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Thrombin Human Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.